In the research and development of new drugs, a series of medium and long-term project plans have been formulated around new products of tyrosine kinase inhibitors, and they are being implemented steadily.

There are 5 chemical synthesis laboratories, 1 comprehensive analysis center, 1 amplification laboratory and 1 pilot plant. The company has a number of senior researchers engaged in the research and development of medicines and intermediates, and with the United States ADVENCHEN LABORATORIES, LLC, Shanghai institute of Organnic Chemistry,Chinese Academy of Sciences,
Chinese Academy of Sciences Shanghai Institute of Materia Medica, Shanghai institute of pharmaceutical industry, Fuzhou University Functional Research Institute, Nanjing Tech University,  Fuzhou University, Changzhou University and other research institutes cooperate to carry out scientific research and development work.